Despite the fact that the functional relevance of some of these aberrantly expressed proteins (TIGIT, CD276, or LILRB4) still remains to be elucidated in the context of CLL, our observation is of particular interest for the development of new therapeutic strategies in CLL. The gene discussed is LILRB4; the disease is B-cell chronic lymphocytic leukemia.